BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

FDA Clears Tandem Diabetes Care's Diabetes Management Application


2/26/2013 9:06:27 AM

SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. ("Tandem") today announced that its t:connect Diabetes Management Application, the web-based data management companion to the t:slim® Insulin Pump, has been cleared for use by the U.S. Food and Drug Administration (FDA).

The t:connect Application is a Mac and PC-compatible data management software application that provides t:slim Pump users and their healthcare providers a fast, easy, and visual way to display data from the pump and supported blood glucose meters. This software empowers users to quickly and easily identify meaningful information and patterns, which allows them to fine-tune therapy and lifestyle choices for improved diabetes management.

The t:connect Application makes pump and meter data simple to understand with color-coded graphs and interactive reports. Data uploads from the t:slim Pump to the t:connect Application through a micro-USB connection without interrupting insulin delivery.

"We developed the t:connect Application with the same emphasis on ease of use employed in the development of the t:slim Insulin Pump," said Kim Blickenstaff, president and CEO of Tandem. "The software was designed for speed and simplicity to encourage users to upload and review their data more frequently, and to improve the efficiency and productivity of visits with healthcare providers."

All t:slim Pump users will be able to download the t:connect application from Tandem's website by the end of March 2013.

To learn more about the t:connect Diabetes Management Application, visit www.tandemdiabetes.com/tconnect.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a privately held company dedicated to advancing the management of diabetes through novel technologies. The Company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes Care is based in San Diego, Calif.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim and #tconnect.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetesCorp.

t:slim and Tandem Diabetes Care are registered trademarks, and t:connect is a trademark, of Tandem Diabetes Care, Inc.

SOURCE Tandem Diabetes Care, Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->